Emdrix Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Emdrix Pharmaceuticals: trust score, financial health, credit view, compliance, directors, growth and distress…

2012-09-03 Bangalore, Karnataka Active Unlisted Active Non-Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Emdrix Pharmaceuticals — 360° Intelligence Report

Generated from MCA filings & public records
40/100
Trust Score
Caution Indicated

Emdrix Pharmaceuticals is assessed as Caution Indicated with a Trust Score of 40/100. Emdrix Pharmaceuticals is an active private limited indian non-government company incorporated in 2012, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 01 Nov 2026 from the latest processed filings. Emdrix Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
40/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
25/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 1 open (2.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of Mysore1 48.0 cr
Compliance Score: 25/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2017 - filings overdue.
  • Flagged by authority: EPFO.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
NIRANJAN SURENDRA SHETTY 01234567 Director 01/04/2018 6 yrs Approved
NAMITHA ANANTH 01234567 Director 01/04/2018 6 yrs Approved
SUBBARAJU ANANTH NARASIMHA 01234567 Director 01/04/2018 6 yrs Approved
SHARMARASHMI 01234567 Director 01/04/2018 6 yrs Approved
HINDUPUR NARASINGARAO UDAYASIMHA 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • NIRANJAN SURENDRA SHETTY has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: NAMITHA ANANTH (Whole-time director) · SUBBARAJU ANANTH NARASIMHA (Whole-time director) · SHARMARASHMI (Whole-time director) · HINDUPUR NARASINGARAO UDAYASIMHA (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 35
Growth signals & trust indicators
Steady revenue growth: +38% over 3 year(s).
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
Operating for 14+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 24% in a year.
Negative net worth.
Statutory filings appear overdue.
Compliance score is weak (25/100).
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence32/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment30/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 2.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view47/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
24 Dec 2016
Securities allotted
32692 Equity Shares Without Differential Rights - 1.00 cr raised
08 Dec 2016
Director ceased
NIRANJAN SURENDRA SHETTY
16 Jul 2016
Director appointed
NIRANJAN SURENDRA SHETTY (Director)
30 May 2016
Securities allotted
27282 Equity Shares Without Differential Rights - 25.10 Lakh raised
19 Mar 2016
Director ceased
SOMASHEKHAR SHANKAR KAGATI
26 May 2015
Charge created
State Bank Of Mysore - 2.00 cr
30 Sep 2014
Director ceased
NAMITHA ANANTH
Director ceased
SUBBARAJU ANANTH NARASIMHA
Director ceased
SHARMARASHMI
Director ceased
HINDUPUR NARASINGARAO UDAYASIMHA
03 Sep 2012
Incorporated
Registered with Roc Bangalore
Director appointed
NAMITHA ANANTH (Whole-time director)
Director appointed
SUBBARAJU ANANTH NARASIMHA (Whole-time director)
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 3 financial year(s).
Net profit margin moved from 61% to 38%.
5 active director(s) / partner(s); review board churn before relying on management continuity.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Prajna Traders Private Limited U74120UP2014PTC067081 Mathura, Uttar Pradesh, India
Ask Metal Private Limited U74990WB2005PTC106710 Kolkata, West Bengal, India
Real Value Info Solutions Private Limited U67120PB2000PTC023555 Ludhiana, Punjab, India
Auto Syndicate Private Limited U31900TN1985PTC011878 Madurai, Tamil Nadu, India
United Trade. Net (India) Private Limited U74991UP2006PTC032597 Kanpur, Uttar Pradesh, India
Jems Distributors Private Limited U51100KL2013PTC035299 Trivandrum, Kerala, India
Prakash Creations Private Limited . U51909WB1997PTC082461 Kolkata, West Bengal, India
Suptha Mahalakshmi Steels Private Limited U27101AP2014PTC092532 Vizianagaram, Andhra Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Emdrix Pharmaceuticals before audits and certifications: compliance score 25/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Emdrix Pharmaceuticals: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Emdrix Pharmaceuticals - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 40/100, distress signals and MSME payment-delay disclosures - know whether Emdrix Pharmaceuticals pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Emdrix Pharmaceuticals - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Emdrix Pharmaceuticals an active company?

Emdrix Pharmaceuticals has MCA status “Active” with a compliance score of 25/100 (Caution Indicated).

Is Emdrix Pharmaceuticals financially healthy?

Emdrix Pharmaceuticals has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Emdrix Pharmaceuticals?

Its overall Trust Score is 40/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Emdrix Pharmaceuticals?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Emdrix Pharmaceuticals have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Emdrix Pharmaceuticals up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 25/100 (Caution Indicated).

Is it risky to lend to Emdrix Pharmaceuticals?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.